Suppr超能文献

用碘、左甲状腺素或两者联合治疗碘缺乏性甲状腺肿。

Treatment of iodine deficiency goiter with iodine, levothyroxine or a combination of both.

作者信息

Hintze G, Köbberling J

机构信息

Department of Medicine Ferdinand-Sauerbruch-Hospital Wuppertal, Germany.

出版信息

Thyroidology. 1992 Apr;4(1):37-40.

PMID:1284331
Abstract

During recent years several studies have been published comparing different ways of pharmacological treatment of a goiter due to iodine deficiency. These studies usually were performed with 300 to 500 micrograms of iodine, 100 to 150 micrograms levothyroxine, or a combination of in most cases 100 micrograms levothyroxine and 100 micrograms iodine. The largest data have been accumulated in 166 patients with in most cases diffuse goiter. Group A (n = 61) received 150 micrograms levothyroxine per day, group B (n = 50) 400 micrograms iodine per day and group C (n = 55) a combination of 75 micrograms levothyroxine and 200 micrograms iodine per day. During the eight months of therapy, in all three groups a significant and comparable mean decrease in goiter size was documented (-32.1% in group A, -37.3% in group B and -38.7% in group C [n.s. between the three groups]). Striking differences between the three groups are evident in the changes of basal and thyrotropin releasing hormone (TRH) stimulated thyrotropin (TSH). In group A, after eight months a sharp and significant decrease of TSH occurred (from 1.2 mU/l to 0.4 mU/l; mean; p < 0.05), while in group B TSH showed only a minor decrease (from 1.3 mU/l to 0.9 mU/l) and remained significantly higher compared to both, group A and C (p < 0.01). Similar changes were documented when the TSH after TRH administration was calculated. It is concluded, that all three therapeutic approaches are effective for goiter reduction.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

近年来,已经发表了几项研究,比较了因碘缺乏引起的甲状腺肿的不同药物治疗方法。这些研究通常使用300至500微克碘、100至150微克左甲状腺素,或在大多数情况下使用100微克左甲状腺素和100微克碘的组合。在166例大多数为弥漫性甲状腺肿的患者中积累了最多的数据。A组(n = 61)每天接受150微克左甲状腺素,B组(n = 50)每天接受400微克碘,C组(n = 55)每天接受75微克左甲状腺素和200微克碘的组合。在八个月的治疗期间,所有三组甲状腺肿大小均有显著且相当的平均减小记录(A组为-32.1%,B组为-37.3%,C组为-38.7%[三组之间无显著差异])。三组之间在基础促甲状腺激素和促甲状腺激素释放激素(TRH)刺激的促甲状腺激素(TSH)变化方面存在明显差异。在A组中,八个月后TSH急剧且显著下降(从1.2 mU/l降至0.4 mU/l;平均值;p < 0.05),而在B组中TSH仅略有下降(从1.3 mU/l降至0.9 mU/l),并且与A组和C组相比仍显著更高(p < 0.01)。计算TRH给药后的TSH时也记录到了类似变化。得出的结论是,所有三种治疗方法对甲状腺肿缩小均有效。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验